---
title: "Olymvax Biopharmaceuticals released its semi-annual performance, with a net profit attributable to the parent company of 13.2 million yuan, turning a profit from a loss year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255017716.md"
description: "According to the Zhitong Finance APP, Olymvax Biopharmaceuticals disclosed its semi-annual report for 2025, reporting revenue of 306 million yuan, a year-on-year increase of 35.17%; net profit attributable to the parent company of 13.2 million yuan, turning from loss to profit year-on-year; net profit excluding non-recurring items of 7.72 million yuan, also turning from loss to profit year-on-year; basic earnings per share of 0.0326 yuan"
datetime: "2025-08-28T12:56:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255017716.md)
  - [en](https://longbridge.com/en/news/255017716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255017716.md)
---

# Olymvax Biopharmaceuticals released its semi-annual performance, with a net profit attributable to the parent company of 13.2 million yuan, turning a profit from a loss year-on-year

According to the Zhitong Finance APP, Olymvax Biopharmaceuticals (688319.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 306 million yuan, a year-on-year increase of 35.17%; net profit attributable to shareholders was 13.2 million yuan, turning from loss to profit year-on-year; net profit excluding non-recurring gains and losses was 7.72 million yuan, also turning from loss to profit year-on-year; basic earnings per share were 0.0326 yuan

### Related Stocks

- [688319.CN](https://longbridge.com/en/quote/688319.CN.md)

## Related News & Research

- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [JCDecaux says vegetated street furniture pilot boosts urban biodiversity in Paris](https://longbridge.com/en/news/287254202.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)